REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

ZENTIVA PHARMA Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Accounting, Tax Preparation, Bookkeeping, and Payroll Services
Full name: ZENTIVA PHARMA Gyogyszermarketing Kereskedelmi es Szolgaltato Korlatolt Felelossegu Tarsasag Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

ZENTIVA PHARMA Gyogyszermarketing Kereskedelmi es Szolgaltato Korlatolt Felelossegu Tarsasag is a pharmaceutical company that operates multiple manufacturing sites worldwide and produces medicines, including brands and generic products, with the aim of making healthcare accessible to all. The company claims to have a strong presence in various regions.

Headquarters
Konyves Kalman korut 11/C
Budapest; Budapest; Postal Code: 1097

Contact Details: Purchase the ZENTIVA PHARMA Kft. report to view the information.

Website: http://www.aramispharma.hu

Basic Information
Total Employees:
Purchase the ZENTIVA PHARMA Kft. report to view the information.
Outstanding Shares:
Purchase the ZENTIVA PHARMA Kft. report to view the information.
Registered Capital:
Purchase the ZENTIVA PHARMA Kft. report to view the information.
Financial Auditors:
Purchase the ZENTIVA PHARMA Kft. report to view the information.
Incorporation Date:
July 21, 2006
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
52.37%
Subsidiaries
Alvopharm Kft. v.a.
Company Performance
Financial values in the chart are available after ZENTIVA PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
24.01%▲
Total operating revenue
22.09%▲
Operating profit (EBIT)
4787.32%▲
EBITDA
516.87%▲
Net Profit (Loss) for the Period
-71.61%▼
Total assets
3.15%▲
Total equity
2.88%▲
Operating Profit Margin (ROS)
4.04%▲
Net Profit Margin
-20.19%▼
Return on Equity (ROE)
-7.35%▼
Debt to Equity Ratio
1.01%▲
Quick Ratio
0.08%▲
Cash Ratio
-0.18%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo